Insulin degludec Subcutaneous and Ranibizumab Intraocular
Determining the interaction of Insulin degludec Subcutaneous and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Ranibizumab ophthalmic
- Insulin degludec Subcutaneous-Ranitidine
- Insulin degludec Subcutaneous-Ranitidine Capsule
- Insulin degludec Subcutaneous-Ranitidine Hydrochloride
- Insulin degludec Subcutaneous-Ranitidine Injection
- Insulin degludec Subcutaneous-Ranitidine Suspension
- Ranibizumab Intraocular-Insulin detemir
- Ranibizumab Intraocular-Insulin Detemir (Cartridges and Prefilled Syringes)
- Ranibizumab Intraocular-Insulin Detemir (Vials)
- Ranibizumab Intraocular-Insulin detemir Subcutaneous
- Ranibizumab Intraocular-Insulin glargine
- Ranibizumab Intraocular-Insulin Glargine (U-100) Cartridge Systems and Pens